A central management team for advancing research in chromatin biology and epigenetics
Official title: Administrative Core
Funded at Oklahoma Medical Research Foundation · NIH-11019318 · Data updated 2026-11-12
This study is all about helping new scientists who study how our genes are controlled, so they can become independent researchers and discover new ways to understand and treat genetic conditions that might help patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | June 10, 2025 |
| Project end | April 30, 2030 |
| Funding year | 2025 |
| Award (this year) | $549,474 |
| NIH project number | 1P20GM156711-01 |
| Project ID | NIH-11019318 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would be individuals interested in the implications of chromatin biology and epigenetics on health and disease.
✕Less likely to help
Patients with conditions unrelated to chromatin biology or epigenetic mechanisms may not receive direct benefits from this research.
What this research studies
This research focuses on establishing a central management core that supports early career researchers in the field of chromatin biology and epigenetic mechanisms. The team will provide logistical support, mentorship, and resources to help these researchers transition to scientific independence. By promoting multidisciplinary collaboration and managing pilot projects, the core aims to enhance the understanding of how genome regulation works at an epigenetic level. Patients may benefit indirectly through advancements in research that could lead to new treatments or insights into genetic conditions.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in understanding genetic regulation, potentially resulting in new therapies for various conditions.
How similar studies have gone: Other research in the field of chromatin biology and epigenetics has shown promise, indicating that this approach is building on established knowledge rather than being entirely novel.
Where this research is happening
-
Oklahoma Medical Research Foundation
Oklahoma City, United States Active
Researchers
- Principal investigator: Freeman, Willard M — Oklahoma Medical Research Foundation
- Study coordinator: Freeman, Willard M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.